Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $750M (100.0% shares, 0.0% debt)

Holdings (28)

GLOBAL BLOOD THERAPEUTICS IN 10.7%
Value $80.08M Shares 1,175,879 Est. Cost $30.85 Unrealized
MIRATI THERAPEUTICS INC 7.9%
Value $59.39M Shares 850,385 Est. Cost $76.94 Unrealized
INCY INCYTE CORP 6.9%
Value $51.52M Shares 773,082 Est. Cost $74.39 Unrealized -0.7%
ASND ASCENDIS PHARMA A/S 6.8%
Value $51.36M Shares 497,347 Est. Cost $117.62 Unrealized
LEGN LEGEND BIOTECH CORP 5.9%
Value $43.92M Shares 1,076,591 Est. Cost $42.97 Unrealized
BIIB BIOGEN INC 5.5%
Value $41.28M Shares 154,605 Est. Cost $212.38 Unrealized 0.0%
BIIB BIOGEN INC 5.3%
Value $40.05M Shares 150,000 Est. Cost $212.38 Unrealized 0.0%
IMCR IMMUNOCORE HLDGS PLC 4.8%
Value $36.29M Shares 773,079 Est. Cost $34.60 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 4.5%
Value $33.56M Shares 1,636,211 Est. Cost $18.35 Unrealized -2.0%
ARGX ARGENX SE 4.2%
Value $31.88M Shares 90,297 Est. Cost $378.46 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 3.9%
Value $29.43M Shares 140,561 Est. Cost $197.37 Unrealized +13.3%
AKERO THERAPEUTICS INC 3.8%
Value $28.37M Shares 833,265 Est. Cost $34.05 Unrealized
BCYC BICYCLE THERAPEUTICS PLC 3.6%
Value $26.95M Shares 1,158,686 Est. Cost $17.40 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 3.5%
Value $26.08M Shares 1,085,142 Est. Cost $18.57 Unrealized +20.8%
AXSM AXSOME THERAPEUTICS INC 3.1%
Value $23.21M Shares 520,080 Est. Cost $49.97 Unrealized 0.0%
HORIZON THERAPEUTICS PUB L 2.9%
Value $21.75M Shares 351,405 Est. Cost $61.89 Unrealized
ALPINE IMMUNE SCIENCES INC 2.1%
Value $15.95M Shares 2,214,722 Est. Cost $7.76 Unrealized
PRTA PROTHENA CORP PLC 1.9%
Value $14.3M Shares 235,826 Est. Cost $31.61 Unrealized 0.0%
ARVN ARVINAS INC 1.7%
Value $12.63M Shares 283,777 Est. Cost $74.11 Unrealized -34.5%
ESPR ESPERION THERAPEUTICS INC NE 1.5%
Value $11.52M Shares 1,719,831 Est. Cost $6.77 Unrealized +1.4%
MERUS N V 1.5%
Value $11.3M Shares 564,214 Est. Cost $23.80 Unrealized
G1 THERAPEUTICS INC 1.5%
Value $11.05M Shares 884,574 Est. Cost $12.49 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 1.4%
Value $10.2M Shares 519,256 Est. Cost $20.39 Unrealized 0.0%
OYSTER PT PHARMA INC 1.2%
Value $9.264M Shares 1,648,316 Est. Cost $10.18 Unrealized
TGTX TG THERAPEUTICS INC 1.2%
Value $8.912M Shares 1,505,479 Est. Cost $6.24 Unrealized +5.0%
POSEIDA THERAPEUTICS INC 1.0%
Value $7.307M Shares 2,070,108 Est. Cost $3.53 Unrealized
VOR BIOPHARMA INC 0.9%
Value $6.781M Shares 1,703,645 Est. Cost $7.36 Unrealized
MIST MILESTONE PHARMACEUTICALS IN 0.8%
Value $5.828M Shares 634,211 Est. Cost $7.58 Unrealized 0.0%